Hypothesis

Age-related methylation at specific CpG sites alters nucleosome stability, making those DNA regions more prone to cleavage by DNASE1L3. This methylation‑dependent fragility skews cfDNA toward short fragments (70‑150 bp), creating a measurable fragmentation index that mirrors epigenetic aging clocks. Consequently, the cfDNA fragmentation pattern is not merely a passive readout of cell death but an active contributor to the biomarker signal.

Mechanistic Rationale

1. Methylation affects DNA mechanics – 5‑methylcytosine increases base‑pair stacking and reduces helical flexibility, which can destabilize nucleosome wrapping at certain sequences, especially those enriched for CpG islands.
2. Nuclease accessibility – DNASE1L3 preferentially cleaves linker DNA that is less protected by nucleosomes. If methylation reduces nucleosome occupancy at specific loci, those sites become hotspots for DNASE1L3 digestion, enriching short fragments derived from methylated regions.
3. Feedback to inflammaging – Short cfDNA fragments containing methylated motifs activate cytosolic DNA sensors (e.g., cGAS‑STING), promoting type‑I interferon release and perpetuating low‑grade inflammation, which in turn drives further methylation changes at immune‑related genes.
4. Tissue‑specific bias – Tissues with high transcriptional activity (e.g., lymphocytes) already show higher fragmentation due to reduced nucleosome protection. Age‑related methylation amplifies this effect, explaining why the fragmentation index correlates with PBMC gene expression (Spearman rho ~ 0.27) and why cfDNA clocks can be built from as few as 48 CpGs that reside in nucleosome‑sensitive sequences.

Testable Predictions

• In vitro reconstitution – Nucleosomes assembled on methylated versus unmethylated DNA fragments containing a predictor CpG will show differential susceptibility to DNASE1L3 cleavage; methylated nucleosomes will yield a higher proportion of sub‑120 bp products.
• Nuclease inhibition – Treating primary human blood cultures with a DNASE1L3‑specific inhibitor will decrease the short‑to‑long fragment ratio without significantly altering methylation levels at the 48‑CpG clock sites over 24 h.
• Temporal ordering – In a longitudinal cohort, increases in the fragmentation index will precede detectable methylation changes at predictor CpGs by at least one sampling interval, indicating that fragmentation drives epigenetic drift rather than merely reflecting it.
• Rescue experiment – Overexpressing histone H1 or a nucleosome‑stabilizing chaperone in cultured cells will protect methylated DNA from DNASE1L3 digestion, normalizing fragment size distribution and attenuating the inflammagenic cfDNA signal.

Falsifiability

If any of the following observations hold, the hypothesis is refuted:

• Methylated and unmethylated nucleosomes show identical DNASE1L3 cleavage rates under identical conditions.
• DNASE1L3 inhibition fails to alter the short‑fragment proportion in vivo despite adequate target engagement.
• Changes in fragmentation index consistently lag behind methylation shifts at clock CpGs across multiple time points.
• Artificial stabilization of nucleosomes does not modify cfDNA fragment size or inflammagenic signaling.

By linking epigenetic marks to biophysical nucleosome properties and nuclease activity, this hypothesis transforms cfDNA fragmentation from a correlative readout into a mechanistic driver of aging biomarkers, offering concrete avenues for intervention and validation.